{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T02:35:55Z","timestamp":1787020555096,"version":"build-2736575974"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,5,14]],"date-time":"2018-05-14T00:00:00Z","timestamp":1526256000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81471073"],"award-info":[{"award-number":["81471073"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003399","name":"Shanghai Science and Technology Committee","doi-asserted-by":"crossref","award":["13441900303"],"award-info":[{"award-number":["13441900303"]}],"id":[{"id":"10.13039\/501100003399","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Excellent Member Program of Zhongshan Hospital Fudan University","award":["2015ZSYXGG1"],"award-info":[{"award-number":["2015ZSYXGG1"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Lipids Health Dis"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1186\/s12944-018-0762-0","type":"journal-article","created":{"date-parts":[[2018,5,14]],"date-time":"2018-05-14T11:52:08Z","timestamp":1526298728000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":64,"title":["Metformin attenuates triglyceride accumulation in HepG2 cells through decreasing stearyl-coenzyme A desaturase 1 expression"],"prefix":"10.1186","volume":"17","author":[{"given":"Xiaopeng","family":"Zhu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongmei","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingfeng","family":"Xia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinxia","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xi","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoyang","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hua","family":"Bian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoying","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,5,14]]},"reference":[{"issue":"2","key":"762_CR1","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1038\/nrgastro.2016.160","volume":"14","author":"SR Wesolowski","year":"2017","unstructured":"Wesolowski SR, Kasmi KC, Jonscher KR, Friedman JE. Developmental origins of NAFLD: a womb with a clue. Nat Rev Gastroenterol Hepatol. 2017;14(2):81\u201396.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"1","key":"762_CR2","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1002\/hep.28431","volume":"64","author":"ZM Younossi","year":"2016","unstructured":"Younossi ZM, Koenig AB, Abdelatif D, Fazel Y, Henry L, Wymer M. Global epidemiology of nonalcoholic fatty liver disease-meta-analytic assessment of prevalence, incidence, and outcomes. Hepatology. 2016;64(1):73\u201384.","journal-title":"Hepatology"},{"issue":"Suppl 1","key":"762_CR3","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1111\/jgh.12036","volume":"28","author":"JG Fan","year":"2013","unstructured":"Fan JG. Epidemiology of alcoholic and nonalcoholic fatty liver disease in China. J Gastroenterol Hepatol. 2013;28(Suppl 1):11\u20137.","journal-title":"J Gastroenterol Hepatol"},{"issue":"6","key":"762_CR4","doi-asserted-by":"publisher","first-page":"2231","DOI":"10.1210\/jc.2015-1966","volume":"100","author":"P Portillo-Sanchez","year":"2015","unstructured":"Portillo-Sanchez P, Bril F, Maximos M, Lomonaco R, Biernacki D, Orsak B, et al. High prevalence of nonalcoholic fatty liver disease in patients with type 2 diabetes mellitus and normal plasma aminotransferase levels. J Clin Endocrinol Metab. 2015;100(6):2231\u20138.","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"762_CR5","doi-asserted-by":"publisher","first-page":"1174","DOI":"10.1002\/hep.26717","volume":"59","author":"MJ Armstrong","year":"2014","unstructured":"Armstrong MJ, Adams LA, Canbay A, Syn WK. Extrahepatic complications of nonalcoholic fatty liver disease. Hepatology. 2014;59(3):1174\u201397.","journal-title":"Hepatology"},{"key":"762_CR6","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.metabol.2017.11.003","volume":"79","author":"A Mantovani","year":"2017","unstructured":"Mantovani A, Zaza G, Byrne CD, Lonardo A, Zoppini G, Bonora E, et al. Nonalcoholic fatty liver disease increases risk of incident chronic kidney disease: a systematic review and meta-analysis. Metabolism. 2017;79:64\u201376.","journal-title":"Metabolism"},{"key":"762_CR7","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1186\/s12967-016-0766-3","volume":"14","author":"MF Xia","year":"2016","unstructured":"Xia MF, Lin HD, Yan HM, Bian H, Chang XX, Zhang LS, et al. The association of liver fat content and serum alanine aminotransferase with bone mineral density in middle-aged and elderly Chinese men and postmenopausal women. J Transl Med. 2016;14:11.","journal-title":"J Transl Med"},{"issue":"6","key":"762_CR8","doi-asserted-by":"publisher","first-page":"e0157515","DOI":"10.1371\/journal.pone.0157515","volume":"11","author":"D Wang","year":"2016","unstructured":"Wang D, Lin H, Xia M, Aleteng Q, Li X, Ma H, et al. Vitamin D levels are inversely associated with liver fat content and risk of non-alcoholic fatty liver disease in a Chinese middle-aged and elderly population: the shanghai Changfeng study. PLoS One. 2016;11(6):e0157515.","journal-title":"PLoS One"},{"issue":"10","key":"762_CR9","doi-asserted-by":"publisher","first-page":"e0140379","DOI":"10.1371\/journal.pone.0140379","volume":"10","author":"H Lin","year":"2015","unstructured":"Lin H, Li Q, Liu X, Ma H, Xia M, Wang D, et al. Liver fat content is associated with elevated serum uric acid in the Chinese middle-aged and elderly populations: shanghai Changfeng study. PLoS One. 2015;10(10):e0140379.","journal-title":"PLoS One"},{"issue":"6","key":"762_CR10","doi-asserted-by":"publisher","first-page":"1138","DOI":"10.1136\/gutjnl-2017-313884","volume":"66","author":"LA Adams","year":"2017","unstructured":"Adams LA, Anstee QM, Tilg H, Targher G. Non-alcoholic fatty liver disease and its relationship with cardiovascular disease and other extrahepatic diseases. Gut. 2017;66(6):1138\u201353.","journal-title":"Gut"},{"issue":"12","key":"762_CR11","doi-asserted-by":"publisher","first-page":"1279","DOI":"10.1007\/s40618-017-0708-9","volume":"40","author":"ALL Rocha","year":"2017","unstructured":"Rocha ALL, Faria LC, Guimaraes TCM, Moreira GV, Candido AL, Couto CA, et al. Non-alcoholic fatty liver disease in women with polycystic ovary syndrome: systematic review and meta-analysis. J Endocrinol Investig. 2017;40(12):1279\u201388.","journal-title":"J Endocrinol Investig"},{"issue":"5","key":"762_CR12","doi-asserted-by":"publisher","first-page":"1029","DOI":"10.1016\/j.jhep.2008.11.021","volume":"50","author":"Y Li","year":"2009","unstructured":"Li Y, Xu C, Yu C, Xu L, Miao M. Association of serum uric acid level with non-alcoholic fatty liver disease: a cross-sectional study. J Hepatol. 2009;50(5):1029\u201334.","journal-title":"J Hepatol"},{"issue":"2","key":"762_CR13","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1111\/j.1365-2036.2008.03869.x","volume":"29","author":"R Loomba","year":"2009","unstructured":"Loomba R, Lutchman G, Kleiner DE, Ricks M, Feld JJ, Borg BB, et al. Clinical trial: pilot study of metformin for the treatment of non-alcoholic steatohepatitis. Aliment Pharmacol Ther. 2009;29(2):172\u201382.","journal-title":"Aliment Pharmacol Ther"},{"issue":"5","key":"762_CR14","doi-asserted-by":"publisher","first-page":"1082","DOI":"10.1111\/j.1572-0241.2005.41583.x","volume":"100","author":"E Bugianesi","year":"2005","unstructured":"Bugianesi E, Gentilcore E, Manini R, Natale S, Vanni E, Villanova N, et al. A randomized controlled trial of metformin versus vitamin E or prescriptive diet in nonalcoholic fatty liver disease. Am J Gastroenterol. 2005;100(5):1082\u201390.","journal-title":"Am J Gastroenterol"},{"issue":"6","key":"762_CR15","doi-asserted-by":"publisher","first-page":"1112","DOI":"10.1007\/s00125-016-3952-1","volume":"59","author":"K Cusi","year":"2016","unstructured":"Cusi K. Treatment of patients with type 2 diabetes and non-alcoholic fatty liver disease: current approaches and future directions. Diabetologia. 2016;59(6):1112\u201320.","journal-title":"Diabetologia"},{"issue":"4","key":"762_CR16","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1586\/17474124.2014.894880","volume":"8","author":"S Rouabhia","year":"2014","unstructured":"Rouabhia S, Milic N, Abenavoli L. Metformin in the treatment of non-alcoholic fatty liver disease: safety, efficacy and mechanism. Expert Rev Gastroenterol Hepatol. 2014;8(4):343\u20139.","journal-title":"Expert Rev Gastroenterol Hepatol"},{"key":"762_CR17","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1111\/j.1749-6632.2011.06303.x","volume":"1243","author":"H Sampath","year":"2011","unstructured":"Sampath H, Ntambi JM. The role of stearoyl-CoA desaturase in obesity, insulin resistance, and inflammation. Ann N Y Acad Sci. 2011;1243:47\u201353.","journal-title":"Ann N Y Acad Sci"},{"issue":"1","key":"762_CR18","doi-asserted-by":"publisher","first-page":"E28","DOI":"10.1152\/ajpendo.90897.2008","volume":"297","author":"CM Paton","year":"2009","unstructured":"Paton CM, Ntambi JM. Biochemical and physiological function of stearoyl-CoA desaturase. Am J Physiol Endocrinol Metab. 2009;297(1):E28\u201337.","journal-title":"Am J Physiol Endocrinol Metab"},{"issue":"5","key":"762_CR19","doi-asserted-by":"publisher","first-page":"1493","DOI":"10.2337\/db10-0393","volume":"60","author":"E Kim","year":"2011","unstructured":"Kim E, Liu NC, Yu IC, Lin HY, Lee YF, Sparks JD, et al. Metformin inhibits nuclear receptor TR4-mediated hepatic Stearoyl-CoA desaturase 1 gene expression with altered insulin sensitivity. Diabetes. 2011;60(5):1493\u2013503.","journal-title":"Diabetes"},{"issue":"4","key":"762_CR20","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1016\/j.cmet.2012.09.002","volume":"16","author":"W Shao","year":"2012","unstructured":"Shao W, Espenshade PJ. Expanding roles for SREBP in metabolism. Cell Metab. 2012;16(4):414\u20139.","journal-title":"Cell Metab"},{"issue":"4","key":"762_CR21","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1016\/j.cmet.2011.03.009","volume":"13","author":"Y Li","year":"2011","unstructured":"Li Y, Xu S, Mihaylova MM, Zheng B, Hou X, Jiang B, et al. AMPK phosphorylates and inhibits SREBP activity to attenuate hepatic steatosis and atherosclerosis in diet-induced insulin-resistant mice. Cell Metab. 2011;13(4):376\u201388.","journal-title":"Cell Metab"},{"issue":"2","key":"762_CR22","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1530\/JOE-15-0409","volume":"229","author":"H Xu","year":"2016","unstructured":"Xu H, Zhou Y, Liu Y, Ping J, Shou Q, Chen F, et al. Metformin improves hepatic IRS2\/PI3K\/Akt signaling in insulin-resistant rats of NASH and cirrhosis. J Endocrinol. 2016;229(2):133\u201344.","journal-title":"J Endocrinol"},{"key":"762_CR23","doi-asserted-by":"publisher","first-page":"716404","DOI":"10.1155\/2012\/716404","volume":"2012","author":"A Mazza","year":"2012","unstructured":"Mazza A, Fruci B, Garinis GA, Giuliano S, Malaguarnera R, Belfiore A. The role of metformin in the management of NAFLD. Exp Diabetes Res. 2012;2012:716404.","journal-title":"Exp Diabetes Res"},{"issue":"4","key":"762_CR24","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1055\/s-0033-1358523","volume":"33","author":"X Xu","year":"2013","unstructured":"Xu X, So JS, Park JG, Lee AH. Transcriptional control of hepatic lipid metabolism by SREBP and ChREBP. Semin Liver Dis. 2013;33(4):301\u201311.","journal-title":"Semin Liver Dis"},{"issue":"4","key":"762_CR25","doi-asserted-by":"publisher","first-page":"E730","DOI":"10.1152\/ajpendo.00225.2016","volume":"311","author":"BK Smith","year":"2016","unstructured":"Smith BK, Marcinko K, Desjardins EM, Lally JS, Ford RJ, Steinberg GR. Treatment of nonalcoholic fatty liver disease: role of AMPK. Am J Physiol Endocrinol Metab. 2016;311(4):E730\u201340.","journal-title":"Am J Physiol Endocrinol Metab"},{"issue":"12","key":"762_CR26","doi-asserted-by":"publisher","first-page":"1649","DOI":"10.1038\/nm.3372","volume":"19","author":"MD Fullerton","year":"2013","unstructured":"Fullerton MD, Galic S, Marcinko K, Sikkema S, Pulinilkunnil T, Chen ZP, et al. Single phosphorylation sites in Acc1 and Acc2 regulate lipid homeostasis and the insulin-sensitizing effects of metformin. Nat Med. 2013;19(12):1649\u201354.","journal-title":"Nat Med"}],"container-title":["Lipids in Health and Disease"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12944-018-0762-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12944-018-0762-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12944-018-0762-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,13]],"date-time":"2019-05-13T20:51:54Z","timestamp":1557780714000},"score":1,"resource":{"primary":{"URL":"https:\/\/lipidworld.biomedcentral.com\/articles\/10.1186\/s12944-018-0762-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,5,14]]},"references-count":26,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["762"],"URL":"https:\/\/doi.org\/10.1186\/s12944-018-0762-0","relation":{},"ISSN":["1476-511X"],"issn-type":[{"value":"1476-511X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,5,14]]},"assertion":[{"value":"28 February 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 April 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 May 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare that they have no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"114"}}